Navigation Links
High Urate Levels in Blood Linked to Reduced Parkinson's Risk

th Parkinson's disease.

A team of researchers led by Alberto Ascherio, Associate Professor of Nutrition and Epidemiology at HSPH and senior author of the study and Michael Schwarzschild a movement disorder specialist at Massachusetts General Hospital then followed up on this clue and accessed the databases of two large, randomized studies conducted among patients with early Parkinson's disease.

The preliminary results, presented in abstract form at recent meetings, showed a slower progression of the disease among individuals with high blood urate.

"It is still uncertain whether urate exerts a neuroprotective effect, but approaches to elevating urate levels are nonetheless worth considering as a potential neuroprotective strategy," said Ascherio.

"But elevating blood urate increases the risk of kidney stones and may have adverse cardiovascular effects and should only be attempted in the context of a closely monitored randomized trial until beneficial effects are proven," he added.

The study was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke, the Kinetics Foundation and the Intramural Research Program of the National Institutes of Health/National Institute of Environmental Health Sciences.

The findings were published online on June 20, 2007 in The American Journal of Epidemiology and will appear in an upcoming print issue of the journal.


'"/>




Page: 1 2

Related medicine news :

1. Urate Reduces the Risk of Parkinsons Disease
2. Levels Of Blood Proteins May Help Heart Disease Care
3. Elevated Ozone Levels Hurt Sperm Count
4. Elevating Manganese Levels hold back HIV
5. High Levels of Protein Linked to Brain Shrinkage
6. Chickens Found To Have High Levels of Arsenic
7. Low Protein Levels A Possible Indicator For A Miscarriage
8. Low Testosterone Levels the Cause Of Depression In Men
9. Weather Found To Play An Important Role In Cholesterol Levels
10. Education Levels Found To Predict Stress
11. Effective Control Of Blood Sugar Levels
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ing in a French school, hospital, metro station, o...e first time to a stiff fine as the first stage of... places went into effect. The ban covers schools,...' offices, sports halls, train stations, airports,...
...ng an outbreak of bird flu in a poultry farm in Su... Reports of an ‘unexplained’ illness// had many ex...ion has been received from The Department of Envir... bird-flu outbreak. This is the second attack of b...
...lipid plays a crucial role in shaping a hollow sph...ave found. It seems to help in organizing// tissue...tions. They found that in the first few days of l...p to form the primitive ectoderm from which embryo...
...lege of Medicine finds that naltrexone may be bene...of this drug is often used to bring// relief to vi...ase is a chronic inflammatory disorder of the inte...0 Americans. The study results were released onlin...
Other Medicine News:Health News:Ceramide Directs Stem Cells in Embryo 2
(Date:9/4/2008)...LBOURNE, Australia, Sept. 4 /- Cytopi...mmencing enrolment for its Phase Ib/II,study of CY...cancer agent,in patients with an aggressive form ...GBM)., The GBM clinical trial is the first Phase ...indications for the company and the second in its,...
(Date:9/4/2008)...actice Bulletin for Obstetrician-Gynecologists Sta...ce Change-Minimally Invasive Interventional,Radiol...With Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRN...al Radiology, a national organization of nearly 4,...onals dedicated to improving health,care through m...
(Date:9/4/2008)...mg cohort demonstrates potent antiviral activity a...profile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-...: IDIX ), a biopharmaceutical company engaged,in ...atment of human viral,and other infectious disease...-of-concept study evaluating IDX899, a non-nucleos...
(Date:9/3/2008)...NJING, China, Sept. 3 /- Si...g manufacturer and supplier of,branded generic pha...-cancer biotech product Endu (also known as Endost...u Phase IV clinical study., At the request of the...,to further validate the safety and therapeutic ef...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3First study examines newly licensed RN work attitudes and intentions 234 1First study examines newly licensed RN work attitudes and intentions 234 2First study examines newly licensed RN work attitudes and intentions 234 3RA Drugs Linked to Slight Skin Cancer Risk 232 1RA Drugs Linked to Slight Skin Cancer Risk 232 2Who will recover spontaneously from hepatitis C virus infection 175 1Who will recover spontaneously from hepatitis C virus infection 175 2Modigene to Present at the Roth 2007 New York Investor Conference 240 1Modigene to Present at the Roth 2007 New York Investor Conference 240 2Modigene to Present at the Roth 2007 New York Investor Conference 240 3
...ELD, Ill., March 29, 2007 /PRNewswire-FirstCall/ -...Phase I/II data for its,adjuvant-free investigatio...nitiate a Phase III clinical trial of the candidat..., The Phase I/II study indicated that Baxter,s H5N...oses, and induces substantial,levels of cross immu...
...ascular Ultrasound Demonstrates Utility in Evaluat...normous Potential for HDL,Therapy , ,PLEASANTON, C...rk),-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. ...pid Sciences, Inc., concluded from,the wide range ...,Cardiology (ACC) Meeting in New Orleans that the ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
The Clinac 2300 C/D family of accelerators are reliable, easy-to-use, flexible and cost-effective systems.
The Clinac 6EX accelerator is a cost-effective choice. Configured for the latest treatment techniques, the Clinac 6EX has the tightest mechanical and dosimetric specifications for any single-energy m
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter.
Medicine Products: